Showing results (381-390 of 1,893,405) with videos related to
Sort By:
Pageof 189,341
Urologic Oncology|June 7, 2021
A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinomaSounak Gupta, William R Sukov, Chad M Vanderbilt, et al.Diabetes|March 29, 2006
Inhibition of glucose-stimulated activation of extracellular signal-regulated protein kinases 1 and 2 by epinephrine in pancreatic beta-cellsTara Beers Gibson, Michael C Lawrence, Craig J Gibson, et al.Oncotarget|March 31, 2016
ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1Simon-Peter Williams, Annie Ogasawara, Jeff N Tinianow, et al.The American Journal of Pathology|December 23, 2022
Deep Learning-Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome PredictionDavid J Ho, Narasimhan P Agaram, Marc-Henri Jean, et al.Archives of Pathology & Laboratory Medicine|July 8, 2011
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimensAziza Nassar, Cynthia Cohen, Sally S Agersborg, et al.Cell Motility and the Cytoskeleton|April 15, 2004
Actin-dependent motility of melanosomes from fish retinal pigment epithelial (RPE) cells investigated using in vitro motility assaysE L McNeil, D Tacelosky, P Basciano, et al.Research Square|August 7, 2024
Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling - A report on the impact of process optimization through the analysis of 4,871 cytology samples profiled by MSK-IMPACTDavid Kim, Chad Vanderbilt, Soo-Ryum Yang, et al.Cell Death & Disease|March 20, 2015
Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancerM K Farrugia, S B Sharma, C-C Lin, et al.Physical Review Letters|October 15, 2016
Magnetoelectric Coupling through the Spin Flop Transition in Ni_{3}TeO_{6}M O Yokosuk, Amal Al-Wahish, Sergey Artyukhin, et al.JCO Precision Oncology|October 7, 2024
Response to Crizotinib After Entrectinib Resistance in ROS1-Rearranged, MET-Amplified Lung AdenocarcinomaVictor R Vaz, Malini M Gandhi, Biagio Ricciuti, et al.Pageof 189,341